Aatru Medical Announces Latin America Distribution Agreement for Their Innovative NPSIMS™ Negative Pressure Surgical Incision Management System
Aatru Medical, LLC (“Aatru”) is pleased to announce a Latin America distribution agreement with Salus Biomedical, for the NPSIMS product. The patented NPSIMS utilizes a safe and innovative solid-state chemical reaction to create and apply negative pressure in the therapeutic range to closed incision sites for up to 7 days. - April 06, 2022
Aatru Medical Announces Clinical Study and Interim Analysis of Their FDA-Approved Negative Pressure Surgical Incision Management System
Aatru Medical Announces Clinical Study and Interim Analysis of their FDA-approved Negative Pressure Surgical Incision Management System NPSIMS in New Zealand, demonstrating efficacy and performance. - October 20, 2021
Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS™ - Negative Pressure Surgical Incision Management System
Aatru Medical, LLC announced U.S. Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electro-mechanical pump, battery, and electronics found in most other negative pressure wound therapy (NPWT) systems being deployed for closed surgical incision applications. - August 24, 2021